MCID: DRG002
MIFTS: 51

Drug-Induced Hepatitis malady

Gastrointestinal diseases category
Download this MalaCard

Summaries for Drug-Induced Hepatitis

About this section


Fully expand this MalaCard
Wikipedia:65 Hepatotoxicity (from hepatic toxicity) implies chemical-driven liver damage. more...

MalaCards based summary: Drug-Induced Hepatitis, also known as hepatitis, chronic, drug-induced, is related to hepatitis and tuberculosis. An important gene associated with Drug-Induced Hepatitis is UGT1A3 (UDP glucuronosyltransferase 1 family, polypeptide A3), and among its related pathways are Etoposide Pathway, Pharmacokinetics/Pharmacodynamics and Carbamazepine Pathway, Pharmacokinetics. The compounds thiopurine and flunitrazepam have been mentioned in the context of this disorder. Affiliated tissues include liver, testes and t cells, and related mouse phenotype homeostasis/metabolism.

Aliases & Classifications for Drug-Induced Hepatitis

About this section

Drug-Induced Hepatitis, Aliases & Descriptions:

Name: Drug-Induced Hepatitis 30 8
Hepatitis, Chronic, Drug-Induced 62
 
Drug-Induced Chronic Hepatitis 8
Hepatitis, Drug-Induced 62


Classifications:

Malacards categories (disease lists): (See all malacards categories)
Anatomical: Gastrointestinal diseases


External Ids:

Disease Ontology8 DOID:2044
SNOMED-CT57 235889003
MeSH34 D056487

Related Diseases for Drug-Induced Hepatitis

About this section

Diseases related to Drug-Induced Hepatitis via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 107)
idRelated DiseaseScoreTop Affiliating Genes
1hepatitis31.2CYP2E1, GPT, ALB, GLUD1, SLC17A5
2tuberculosis30.8CYP2E1, TNF, NAT2, ALB
3autoimmune hepatitis29.8UGT1A1, CYP2D6, CYP2C9, GPT, GSTT1, SLC17A5
4crigler-najjar syndrome10.5UGT1A1
5pulmonary tuberculosis10.4
6gilbert syndrome10.4UGT1A1, NAT2
7brain cancer10.4GSTM1, GSTT1
8asbestosis10.4GSTM1, GSTT1
9neuroleptic malignant syndrome10.4CYP2D6
10fatty liver disease10.4CYP2E1, SLC17A5
11fascioliasis10.4SORD, SLC17A5
12bladder carcinoma in situ10.3NAT2, NAT1, GSTM1
13choledocholithiasis10.3GPT, SLC17A5
14pancreatitis, chronic10.3UGT1A1, CYP2E1, GSTT1
15alcoholic hepatitis10.3CYP2E1, TNF
16open-angle glaucoma10.3GSTT1, GSTM1
17pyridoxine deficiency10.3GPT, SLC17A5
18aplastic anemia10.2CYP2D6, GSTM1, GSTT1
19hepatitis a10.2
20diabetic cataract10.2SORD, CAT
21nasopharynx carcinoma10.2CYP2E1, NAT2, GSTM1, GSTT1
22bladder carcinoma10.2NAT2, NAT1, GSTM1, GSTT1
23endometriosis10.2NAT2, GSTM1, GSTT1
24acute lymphoblastic leukemia, childhood10.2CYP2E1, NAT1, GSTM1, GSTT1
25hepatorenal syndrome10.2ALB
26acute myeloid leukemia, adult10.2GSTM1, GSTT1
27obstructive jaundice10.2GPT, SLC17A5
28transitional cell carcinoma10.2NAT2, NAT1, GSTM1, GSTT1
29gastric adenocarcinoma10.2NAT2, NAT1, GSTM1, GSTT1
30basal cell carcinoma10.2GSTT1, GSTM1, CYP2D6
31senile cataract10.2CAT, GSTM1, GSTT1
32hellp syndrome10.2SLC17A5, GPT
33alcohol abuse10.2CYP2E1, GPT, SLC17A5
34cholelithiasis10.2GPT, UGT1A1
35scrub typhus10.2SLC17A5, GPT
36squamous cell carcinoma of the head and neck10.2CYP2D6, NAT2, GSTM1, GSTT1
37non-hodgkin lymphoma10.1CYP2E1, NAT2, NAT1, GSTM1, GSTT1
38periodontal disease10.1TNF, NAT2, SLC17A5
39kernicterus10.1UGT1A1, ALB
40oral cancer10.1CYP2E1, CAT, GSTM1, GSTT1
41bilirubin metabolic disorder10.1UGT1A3, UGT1A1, ALB
42schizophrenia10.1GLUD1, CYP2C9, CYP2D6, CYP2C19
43laryngeal squamous cell carcinoma10.1CYP2D6, CYP2E1, NAT2, GSTM1, GSTT1
44multiple myeloma10.1
45hyperinsulinism10.1
46dystonia10.1
47melanoma10.1
48meningitis10.1
49myeloma10.1
50psoriasis10.1

Graphical network of the top 20 diseases related to Drug-Induced Hepatitis:



Diseases related to drug-induced hepatitis

Symptoms for Drug-Induced Hepatitis

About this section

Drugs & Therapeutics for Drug-Induced Hepatitis

About this section

Drug clinical trials:

Search ClinicalTrials for Drug-Induced Hepatitis

Search NIH Clinical Center for Drug-Induced Hepatitis

Genetic Tests for Drug-Induced Hepatitis

About this section

Anatomical Context for Drug-Induced Hepatitis

About this section

MalaCards organs/tissues related to Drug-Induced Hepatitis:

32
Liver, Testes, T cells

LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine

Cells/anatomical compartments in embryo or adult related to Drug-Induced Hepatitis:
id TissueAnatomical CompartmentCell Relevance
1 LiverLiver LobuleHepatocytes Affected by disease

Animal Models for Drug-Induced Hepatitis or affiliated genes

About this section

MGI Mouse Phenotypes related to Drug-Induced Hepatitis:

36
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053765.7SLC17A5, TNF, SORD, NAT2, NAT1, GHR

Publications for Drug-Induced Hepatitis

About this section

Articles related to Drug-Induced Hepatitis:

(show top 50)    (show all 87)
idTitleAuthorsYear
1
Epstein-Barr Virus Infection Mimicking Drug-Induced Hepatitis in a Critically ill Patient During Antituberculosis Therapy. (25368656)
2014
2
Comment on "No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance" by Ubaldo Visco-Comandini et al. [Dig. Liver Dis. 2014;46:348-52]. (24815081)
2014
3
Comments on 'Risk factors for drug induced hepatitis with first-line antituberculosis drugs in hospitalized patients of pulmonary tuberculosis'. (24823542)
2014
4
A rare coexistence: drug induced hepatitis and meningitis in association with Ibuprofen. (23671551)
2013
5
Cytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohort. (23460870)
2013
6
Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature. (24109195)
2013
7
Anti-tuberculosis drug-induced hepatitis in renal transplant patient with pulmonary and extra pulmonary tuberculosis. (23960791)
2012
8
A Case of Drug-Induced Hepatitis due to Bortezomib in Multiple Myeloma. (22916049)
2012
9
TNF-I+ genetic polymorphism -308G/A and antituberculosis drug-induced hepatitis. (22151084)
2012
10
Drug-induced hepatitis following use of octreotide for long-term treatment of congenital hyperinsulinism. (22850563)
2012
11
Relationship between the polymorphisms of UGT1A6 genes and anti-tuberculosis drug induced hepatic-injury]. (21586239)
2011
12
Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases. (19535968)
2010
13
NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis. (20392357)
2010
14
Drug-induced hepatitis and lupus during infliximab treatment for psoriasis: case report and literature review. (20338127)
2010
15
The effect of GST M1 and GST T1 gene mutations on anti-tuberculous drug induced hepatic injury]. (19576039)
2009
16
Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis. (19891553)
2009
17
Acute drug-induced hepatitis caused by albendazole. (18955802)
2008
18
Acute drug induced hepatitis due to erlotinib. (17228132)
2007
19
Drug induced hepatitis with anti-tubercular chemotherapy: challenges and difficulties in treatment. (18604033)
2007
20
Drug-induced hepatitis in an acromegalic patient during combined treatment with pegvisomant and octreotide long-acting repeatable attributed to the use of pegvisomant. (16728538)
2006
21
Drug-induced hepatitis in a patient with malignant melanoma treated with interferon alfa 2b adjuvantly who had been administered gemfibrozil in therapy. (16645237)
2006
22
Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in pathogenesis of idiosyncratic drug-induced hepatitis. (16467335)
2006
23
A case of acute drug-induced hepatitis. (16607204)
2006
24
Drug-induced hepatitis with saquinavir/ritonavir + rifampin. (15828118)
2005
25
Drug-induced hepatitis, drug-induced autoimmunity or classical autoimmune hepatitis: how can we differentiate? (15492907)
2004
26
Secular increase in the incidence rate of drug-induced hepatitis due to anti-tuberculosis chemotherapy including isoniazid and rifampicin]. (12739393)
2003
27
Antituberculosis drug-induced hepatitis: risk factors, prevention and management. (15332488)
2003
28
Drug-induced hepatitis with autoimmune features during minocycline therapy. (12583618)
2003
29
Clinical pharmacology consultations: consultation requests may be misleading -- an organized approach to drug-induced hepatitis. (12879142)
2003
30
Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. (12668988)
2003
31
Drug-induced hepatitis with hepatic granuloma due to saridon. (12522541)
2002
32
Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. (11915035)
2002
33
Comment: history of drug-induced hepatitis and risk of amoxicillin/clavulanate-induced hepatotoxicity. (11793648)
2001
34
Effects of the enterosorbent SUMS-1 on isoniazid pharmacokinetics and lipid peroxidation in patients with pulmonary tuberculosis and drug-induced hepatic lesions]. (11508231)
2001
35
Drug-induced hepatitis]. (10647202)
1999
36
Nonsteroidal antiinflammatory drug-induced hepatitis. (9533071)
1998
37
Diagnostic value of T cell reactivity in drug induced hepatitis. (9917196)
1998
38
Immunoallergic drug-induced hepatitis: lessons from halothane. (9138123)
1997
39
Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. (9138125)
1997
40
Evidence of antibodies to erythromycin in serum of a patient following an episode of acute drug-induced hepatitis. (8735873)
1996
41
Dystonia and drug-induced hepatitis in a patient treated with clozapine. (7694924)
1995
42
Role of reactive metabolites in drug-induced hepatitis. (8551007)
1995
43
Antituberculosis drug-induced hepatitis and HBsAg carriers. (8369519)
1993
44
Drug induced hepatitis. (1784106)
1991
45
Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. (3540968)
1987
46
Drug-induced hepatitis and lymphocyte transformation test in presence of prostaglandin inhibitor. (2871443)
1986
47
Antituberculosis drug-induced hepatitis--the dangers of rechallenge. (3764619)
1986
48
Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. (4029887)
1985
49
Drug induced hepatitis. (7156818)
1982
50
Recognition, prevention, and treatment of drug-induced hepatitis. (5766633)
1969

Variations for Drug-Induced Hepatitis

About this section

Expression for genes affiliated with Drug-Induced Hepatitis

About this section
Expression patterns in normal tissues for genes affiliated with Drug-Induced Hepatitis

Search GEO for disease gene expression data for Drug-Induced Hepatitis.

Pathways for genes affiliated with Drug-Induced Hepatitis

About this section

Pathways related to Drug-Induced Hepatitis according to GeneCards/GeneDecks:

(show all 27)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
110.0UGT1A1, GSTT1
210.0CYP2E1, CYP2C19
310.0CYP2C9, UGT1A3
49.9GSTT1, GSTM1
59.9CYP2E1, CYP2C9
69.9CYP2C9, UGT1A1
7
Show member pathways
Codeine and morphine metabolism37
9.9CYP2D6, UGT1A1
8
Show member pathways
Glucocorticoid andamp; Mineralcorticoid Metabolism37
9.8UGT1A3, UGT1A1, CYP2E1
99.8CYP2E1, UGT1A1, UGT1A3
10
Show member pathways
acetate conversion to acetyl-CoA37
oxidative ethanol degradation III37
ethanol degradation IV37
9.8CYP2E1, CAT
11
Show member pathways
9.7UGT1A3, UGT1A1, GSTM1
12
Show member pathways
Catalytic cycle of mammalian FMOs37
9.7GSTM1, NAT1, NAT2
13
Show member pathways
9.6CYP2C19, CYP2C9, CYP2E1
14
Show member pathways
9.6UGT1A3, UGT1A1, NAT2, NAT1
15
Show member pathways
9.5CYP2C19, CYP2D6, CYP2C9
169.5UGT1A1, CYP2D6, CYP2E1, NAT2
17
Show member pathways
9.5CYP2C9, CYP2E1, NAT2, NAT1
189.4CYP2C9, CYP2E1, GSTM1, GSTT1
199.3GHR, CYP2C9, CYP2C19
20
Show member pathways
9.3CYP2E1, CYP2C9, CYP2D6, CYP2C19
21
Show member pathways
9.3UGT1A1, CYP2C19, CYP2D6, CYP2C9
22
Show member pathways
Retinol metabolism60
9.1CYP2E1, CYP2C9, CYP2D6, CYP2C19, UGT1A3
23
Show member pathways
9.1UGT1A3, UGT1A1, CYP2C19, CYP2D6, CYP2C9
24
Show member pathways
thioredoxin pathway37
8.6ALB, CAT, TNF
25
Show member pathways
7.8UGT1A3, GSTT1, GSTM1, NAT1, NAT2, CYP2E1
26
Show member pathways
7.8CYP2E1, CYP2C9, CYP2D6, CYP2C19, UGT1A1, UGT1A3
27
Show member pathways
5.6GLUD1, GSTT1, GSTM1, ALB, CAT, NAT1

Compounds for genes affiliated with Drug-Induced Hepatitis

About this section

Compounds related to Drug-Induced Hepatitis according to GeneCards/GeneDecks:

(show top 50)    (show all 595)
idCompoundScoreTop Affiliating Genes
1thiopurine449.5CYP2C19, CYP2D6, NAT2, CYP2C9
2flunitrazepam28 44 1111.5CYP2E1, UGT1A3, UGT1A1, CYP2C19, CYP2C9
3mephenytoin44 50 1111.4CYP2C19, CYP2E1, NAT2, CYP2D6, CYP2C9
4trichloroethylene449.4GSTM1, CYP2E1, GSTT1, GPT, NAT2
5cotinine44 2410.3GSTT1, UGT1A3, GSTM1, NAT2, CYP2D6, UGT1A1
6gsts449.3NAT2, GSTT1, CYP2D6, GSTM1, NAT1, CYP2E1
7arylamine449.2CYP2C19, NAT2, NAT1, GSTM1, GSTT1, CYP2D6
8debrisoquine44 5010.2CYP2E1, GSTM1, NAT2, CYP2C9, CYP2D6, CYP2C19
9tolbutamide44 28 50 1112.2GLUD1, CYP2E1, CYP2C19, NAT2, CYP2D6, CYP2C9
10paraxanthine44 2410.2NAT2, NAT1, CYP2C19, CYP2D6, CYP2C9, CYP2E1
11dapsone44 2 50 1112.2CYP2C9, CYP2D6, CYP2C19, NAT2, CYP2E1, NAT1
12Testosterone sulfate249.2CYP2E1, CYP2C9, CYP2D6, CYP2C19, UGT1A1, UGT1A3
13codeine44 28 50 24 1113.2UGT1A1, CYP2C19, CYP2D6, UGT1A3, CYP2C9, CYP2E1
14aflatoxin b144 2410.2SLC17A5, NAT1, NAT2, GSTT1, GSTM1
15chlorzoxazone44 28 1111.1CYP2D6, CYP2C9, SLC17A5, NAT2, CYP2C19, CYP2E1
16buprenorphine44 28 1111.1SLC17A5, CYP2C9, UGT1A3, CYP2D6, CYP2C19, UGT1A1
17imipramine44 28 50 24 1113.1CYP2C19, CYP2D6, UGT1A3, CYP2C9, CYP2E1, UGT1A1
18rifampin50 1110.1GSTT1, GSTM1, NAT2, UGT1A1, CYP2C19, CYP2C9
19uridine diphosphate449.1UGT1A3, NAT2, CYP2E1, CYP2C9, CYP2D6, UGT1A1
20sulfamethoxazole50 44 1110.9NAT1, GSTM1, ALB, NAT2, CYP2C9
21fluvastatin44 50 28 1111.9CYP2D6, GPT, CYP2C9, UGT1A3, UGT1A1, CYP2C19
22selegiline44 119.8CYP2C19, CYP2D6, CYP2C9, CYP2E1, CAT
23cyclophosphamide44 50 1110.7GSTT1, GSTM1, NAT2, CYP2E1, CYP2D6, CYP2C19
24phenobarbital44 28 50 1111.7CYP2E1, CYP2C9, CYP2C19, UGT1A1, GPT, GSTM1
25antipyrine44 119.7CYP2D6, ALB, CYP2C9, CYP2E1, CYP2C19, SLC17A5
26propofol44 50 1110.7UGT1A1, CYP2C19, CYP2D6, CYP2C9, CYP2E1, ALB
27diclofenac44 28 50 1111.6UGT1A3, UGT1A1, CYP2C19, CYP2D6, CYP2C9, CYP2E1
28estrone44 28 24 1111.6UGT1A3, UGT1A1, CYP2D6, CYP2C9, CYP2E1, ALB
29phenytoin44 50 28 1111.6SLC17A5, ALB, CYP2C9, UGT1A1, CYP2C19, CYP2D6
30rifampicin44 28 6110.5SLC17A5, NAT2, GPT, CYP2E1, CYP2C9, CYP2D6
31olanzapine44 50 28 24 1112.5SLC17A5, GLUD1, ALB, CYP2C9, CYP2D6, CYP2C19
32epoxide448.5GSTT1, GSTM1, NAT1, NAT2, CYP2E1, CYP2C9
33nicotine44 28 50 1111.5UGT1A3, UGT1A1, CYP2E1, GPT, CYP2C9, CYP2D6
34thalidomide44 50 61 1111.3CYP2E1, CYP2C19, CYP2C9, NAT2, TNF, GSTT1
35tamoxifen44 50 28 1111.2SLC17A5, GHR, CYP2E1, CYP2C9, CYP2D6, CYP2C19
36troglitazone44 28 61 1111.1UGT1A1, CYP2C19, UGT1A3, SLC17A5, CYP2C9, TNF
37pioglitazone28 44 50 1111.0CYP2D6, TNF, GPT, SLC17A5, CYP2C19, CYP2C9
38acetaminophen44 2 50 24 1112.0UGT1A1, CYP2C19, CYP2D6, CYP2C9, CYP2E1, GPT
39atorvastatin44 50 28 24 1111.9CYP2C19, CYP2D6, CYP2C9, GPT, TNF, SLC17A5
40valproic acid44 50 24 1110.9CYP2C19, CYP2D6, CYP2C9, CYP2E1, GPT, SLC17A5
41simvastatin44 50 61 28 24 1112.9GPT, UGT1A3, UGT1A1, CYP2C19, CYP2D6, SLC17A5
42vitamin a44 24 119.8GPT, GSTM1, NAT2, CYP2E1, CAT, SLC17A5
43estradiol44 24 119.6ALB, UGT1A3, UGT1A1, CYP2C19, CYP2E1, GHR
44rosiglitazone28 44 50 24 1111.6GPT, CYP2C9, CYP2C19, CYP2D6, TNF, ALB
45uric acid44 248.6GHR, SLC17A5, GPT, GLUD1, ALB, CAT
46isoniazid44 50 119.5CYP2C19, CYP2D6, CYP2C9, CYP2E1, GPT, NAT2
47creatinine447.3SLC17A5, CYP2E1, GPT, SORD, GLUD1, GSTT1
48testosterone44 61 24 119.9UGT1A3, GSTM1, ALB, GHR, CYP2E1, CYP2C9
49lactate446.9SLC17A5, GLUD1, GSTM1, ALB, CAT, SORD
50oxygen44 247.7CYP2D6, GHR, TNF, CYP2E1, GSTM1, GSTT1

GO Terms for genes affiliated with Drug-Induced Hepatitis

About this section

Cellular components related to Drug-Induced Hepatitis according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1endoplasmic reticulum membraneGO:0057898.8CYP2E1, CYP2C9, CYP2D6, CYP2C19, UGT1A1, UGT1A3

Biological processes related to Drug-Induced Hepatitis according to GeneCards/GeneDecks:

(show all 17)
idNameGO IDScoreTop Affiliating Genes
1xenobiotic glucuronidationGO:05269710.2UGT1A3, UGT1A1
2flavonoid glucuronidationGO:05269610.2UGT1A3, UGT1A1
3retinoic acid metabolic processGO:04257310.0UGT1A1, UGT1A3
4drug catabolic processGO:04273710.0CYP2D6, CYP2C9
5omega-hydroxylase P450 pathwayGO:0972679.9CYP2C19, CYP2C9
6oxidative demethylationGO:0709899.8CYP2D6, CYP2C9
7exogenous drug catabolic processGO:0427389.8CYP2C9, CYP2C19
8heterocycle metabolic processGO:0464839.6UGT1A1, CYP2C19, CYP2D6, CYP2E1
9monoterpenoid metabolic processGO:0160989.6CYP2C19, CYP2D6, CYP2C9, CYP2E1
10epoxygenase P450 pathwayGO:0193739.6CYP2C9, CYP2C19
11drug metabolic processGO:0171449.3UGT1A1, CYP2C19, CYP2D6, CYP2C9, CYP2E1
12steroid metabolic processGO:0082029.3UGT1A1, CYP2C19, CYP2D6, CYP2C9, CYP2E1
13oxidation-reduction processGO:0551149.3CYP2C19, CYP2D6, CYP2C9, CYP2E1, GSTT1
14cellular amino acid biosynthetic processGO:0086529.2GLUD1, TNF, GPT
15response to drugGO:0424939.1GSTT1, TNF, CYP2E1, UGT1A1
16xenobiotic metabolic processGO:0068058.3GSTT1, UGT1A1, CYP2C19, CYP2D6, CYP2C9, CYP2E1
17small molecule metabolic processGO:0442816.6CYP2E1, CYP2C9, CYP2D6, CYP2C19, UGT1A1, GPT

Molecular functions related to Drug-Induced Hepatitis according to GeneCards/GeneDecks:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1arylamine N-acetyltransferase activityGO:00406010.1NAT2, NAT1
2(R)-limonene 6-monooxygenase activityGO:05274110.1CYP2C19, CYP2C9
3(S)-limonene 7-monooxygenase activityGO:01867610.1CYP2C19, CYP2C9
4(S)-limonene 6-monooxygenase activityGO:01867510.0CYP2C19, CYP2C9
5monooxygenase activityGO:0044979.6CYP2E1, CYP2C9, CYP2D6, CYP2C19
6steroid hydroxylase activityGO:0083959.6CYP2C9, CYP2C19
7oxidoreductase activityGO:0164919.5CYP2C19, CYP2D6, CYP2C9, CYP2E1
8oxygen bindingGO:0198259.4CYP2C19, CYP2E1, ALB
9antioxidant activityGO:0162099.4ALB, CAT
10iron ion bindingGO:0055069.4CYP2E1, CYP2C9, CYP2D6, CYP2C19
11drug bindingGO:0081449.2CYP2D6, CYP2C9, ALB
12heme bindingGO:0200379.1CYP2C19, CYP2D6, CYP2C9, CYP2E1, CAT
13protein homodimerization activityGO:0428038.7UGT1A3, UGT1A1, GHR, CAT, GSTM1
14enzyme bindingGO:0198998.4GSTM1, UGT1A3, UGT1A1, CYP2C19, CYP2E1, CAT

Products for genes affiliated with Drug-Induced Hepatitis

About this section
  • Antibodies
  • Proteins
  • Lysates

Sources for Drug-Induced Hepatitis

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
51PubMed
52QIAGEN
58SNOMED-CT via Orphanet
62UMLS
63UMLS via Orphanet